These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 26075804)

  • 1. CRISPR/Cas9-Mediated Genome Editing of Epigenetic Factors for Cancer Therapy.
    Yao S; He Z; Chen C
    Hum Gene Ther; 2015 Jul; 26(7):463-71. PubMed ID: 26075804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery and Specificity of CRISPR-Cas9 Genome Editing Technologies for Human Gene Therapy.
    Gori JL; Hsu PD; Maeder ML; Shen S; Welstead GG; Bumcrot D
    Hum Gene Ther; 2015 Jul; 26(7):443-51. PubMed ID: 26068008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of genome editing in studying hearing loss.
    Zou B; Mittal R; Grati M; Lu Z; Shu Y; Tao Y; Feng Y; Xie D; Kong W; Yang S; Chen ZY; Liu X
    Hear Res; 2015 Sep; 327():102-8. PubMed ID: 25987504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of CRISPR/Cas9 genome editing to the study and treatment of disease.
    Pellagatti A; Dolatshad H; Valletta S; Boultwood J
    Arch Toxicol; 2015 Jul; 89(7):1023-34. PubMed ID: 25827103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas9-mediated noncoding RNA editing in human cancers.
    Yang J; Meng X; Pan J; Jiang N; Zhou C; Wu Z; Gong Z
    RNA Biol; 2018 Jan; 15(1):35-43. PubMed ID: 29028415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The application of CRISPR-Cas9 genome editing tool in cancer immunotherapy.
    Wu HY; Cao CY
    Brief Funct Genomics; 2019 Mar; 18(2):129-132. PubMed ID: 29579146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas9: a new and promising player in gene therapy.
    Xiao-Jie L; Hui-Ying X; Zun-Ping K; Jin-Lian C; Li-Juan J
    J Med Genet; 2015 May; 52(5):289-96. PubMed ID: 25713109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma.
    Liu T; Shen JK; Li Z; Choy E; Hornicek FJ; Duan Z
    Cancer Lett; 2016 Apr; 373(1):109-118. PubMed ID: 26806808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9 for genome editing: progress, implications and challenges.
    Zhang F; Wen Y; Guo X
    Hum Mol Genet; 2014 Sep; 23(R1):R40-6. PubMed ID: 24651067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
    Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
    Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CRISPR-Cas system for plant genome editing: advances and opportunities.
    Kumar V; Jain M
    J Exp Bot; 2015 Jan; 66(1):47-57. PubMed ID: 25371501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas9 therapies in experimental mouse models of cancer.
    Estêvão D; Rios Costa N; da Costa RG; Medeiros R
    Future Oncol; 2018 Aug; 14(20):2083-2095. PubMed ID: 30027767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential.
    Oude Blenke E; Evers MJ; Mastrobattista E; van der Oost J
    J Control Release; 2016 Dec; 244(Pt B):139-148. PubMed ID: 27498021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond Native Cas9: Manipulating Genomic Information and Function.
    Mitsunobu H; Teramoto J; Nishida K; Kondo A
    Trends Biotechnol; 2017 Oct; 35(10):983-996. PubMed ID: 28739220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9-mediated genome engineering of CHO cell factories: Application and perspectives.
    Lee JS; Grav LM; Lewis NE; Faustrup Kildegaard H
    Biotechnol J; 2015 Jul; 10(7):979-94. PubMed ID: 26058577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome modification by CRISPR/Cas9.
    Ma Y; Zhang L; Huang X
    FEBS J; 2014 Dec; 281(23):5186-93. PubMed ID: 25315507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruptive non-disruptive applications of CRISPR/Cas9.
    Schmid-Burgk JL
    Curr Opin Biotechnol; 2017 Dec; 48():203-209. PubMed ID: 28633080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application progress of CRISPR/Cas9 genome editing technology in the treatment of HIV-1 infection].
    Han Y; Li QW
    Yi Chuan; 2016 Jan; 38(1):9-16. PubMed ID: 26787519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.